Clinical Trial Update: Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing safety and efficacy of epcoritamab combined with GDP salvage chemotherapy for relapsed/refractory diffuse large B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Epcoritamab (epcoritamab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Dipenkumar Modi | Conditions: Large Cell Lymphoma, Diffuse, Relapsed Cancer | Phase 2 | Status: RECRUITING